ciclopirox has been researched along with terconazole in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Cruz Talonia, F; García Figueroa, RG; Ramírez Palacios, D; Romero Cabello, R; Sauceda, L | 1 |
1 trial(s) available for ciclopirox and terconazole
| Article | Year |
|---|---|
[Effectiveness and safety of ciclopirox olamine 1% vaginal cream versus terconazole 0.8% vaginal cream in the treatment of genital candidiasis].
Topics: Adolescent; Adult; Antifungal Agents; Candidiasis, Vulvovaginal; Ciclopirox; Female; Humans; Pyridones; Triazoles; Vaginal Creams, Foams, and Jellies | 2000 |
1 other study(ies) available for ciclopirox and terconazole
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |